Othello Syndrome Secondary to Ropinirole: A Case Study

This case report describes a forty-two-year-old man with no previous psychiatric history who developed delusional jealousy (Othello Syndrome) associated with ropinirole treatment. Ropinirole is a commonly used dopamine receptor agonist, which was being used to treat his Parkinson's disease, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Kakali, Smith, Abigail, Hayes, Joseph, Chakraborty, Apu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420466/
https://www.ncbi.nlm.nih.gov/pubmed/22953148
http://dx.doi.org/10.1155/2012/353021
_version_ 1782240851959742464
author Pal, Kakali
Smith, Abigail
Hayes, Joseph
Chakraborty, Apu
author_facet Pal, Kakali
Smith, Abigail
Hayes, Joseph
Chakraborty, Apu
author_sort Pal, Kakali
collection PubMed
description This case report describes a forty-two-year-old man with no previous psychiatric history who developed delusional jealousy (Othello Syndrome) associated with ropinirole treatment. Ropinirole is a commonly used dopamine receptor agonist, which was being used to treat his Parkinson's disease, and his delusional symptoms resolved entirely with ropinirole dose reduction.
format Online
Article
Text
id pubmed-3420466
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34204662012-09-05 Othello Syndrome Secondary to Ropinirole: A Case Study Pal, Kakali Smith, Abigail Hayes, Joseph Chakraborty, Apu Case Rep Psychiatry Case Report This case report describes a forty-two-year-old man with no previous psychiatric history who developed delusional jealousy (Othello Syndrome) associated with ropinirole treatment. Ropinirole is a commonly used dopamine receptor agonist, which was being used to treat his Parkinson's disease, and his delusional symptoms resolved entirely with ropinirole dose reduction. Hindawi Publishing Corporation 2012 2012-06-24 /pmc/articles/PMC3420466/ /pubmed/22953148 http://dx.doi.org/10.1155/2012/353021 Text en Copyright © 2012 Kakali Pal et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Pal, Kakali
Smith, Abigail
Hayes, Joseph
Chakraborty, Apu
Othello Syndrome Secondary to Ropinirole: A Case Study
title Othello Syndrome Secondary to Ropinirole: A Case Study
title_full Othello Syndrome Secondary to Ropinirole: A Case Study
title_fullStr Othello Syndrome Secondary to Ropinirole: A Case Study
title_full_unstemmed Othello Syndrome Secondary to Ropinirole: A Case Study
title_short Othello Syndrome Secondary to Ropinirole: A Case Study
title_sort othello syndrome secondary to ropinirole: a case study
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420466/
https://www.ncbi.nlm.nih.gov/pubmed/22953148
http://dx.doi.org/10.1155/2012/353021
work_keys_str_mv AT palkakali othellosyndromesecondarytoropiniroleacasestudy
AT smithabigail othellosyndromesecondarytoropiniroleacasestudy
AT hayesjoseph othellosyndromesecondarytoropiniroleacasestudy
AT chakrabortyapu othellosyndromesecondarytoropiniroleacasestudy

Ejemplares similares